HLM-11466-80151
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 603 / IL
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-20
- 2021-04-28
- 2021-07-06
- 2021-10-05
-
2022-04-06
Survey response — 12 months, dose 2MedDRA: COVID-19, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hives for a couple weeks after contracting covidMedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: Hives for a couple weeks after contracting covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release